Rikke Larsen-Leth

Odense, 5000, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.

Journal: NPJ breast cancer

Published: October 17, 2019

Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome.

Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome.

Journal: Cell reports

Published: October 24, 2018

CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.

CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.

Journal: International journal of cancer

Published: February 14, 2018

Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.

Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.

Journal: Oncoimmunology

Published: December 21, 2016

Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.

Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.

Journal: Stem cells (Dayton, Ohio)

Published: May 25, 2016

NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.

NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.

Journal: Molecular & cellular proteomics : MCP

Published: April 07, 2015

Elucidation of epithelial-mesenchymal transition-related pathways in a triple-negative breast cancer cell line model by multi-omics interactome analysis.

Elucidation of epithelial-mesenchymal transition-related pathways in a triple-negative breast cancer cell line model by multi-omics interactome analysis.

Journal: Integrative biology : quantitative biosciences from nano to macro

Published: August 16, 2014

S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.

S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.

Journal: International journal of cancer

Published: July 11, 2014

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: September 18, 2013

Identification and characterization of a chitin-binding protein purified from coelomic fluid of the lugworm Arenicola marina defining a novel protein sequence family.

Identification and characterization of a chitin-binding protein purified from coelomic fluid of the lugworm Arenicola marina defining a novel protein sequence family.

Journal: The Journal of biological chemistry

Published: November 02, 2012

Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.

Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.

Journal: Cancer genomics & proteomics

Published: September 20, 2012

Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.

Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.

Journal: Molecular medicine (Cambridge, Mass.)

Published: February 28, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026